A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT00358930 · COMPLETED

Trial details

NCT number: NCT00358930
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms Carcinoma, Squamous Cell

Start date: 2006-07-01
Primary completion: 2007-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.